Skip to content

BELESSENTIAL: value indication

Roughly what is an SME worth on what it filed? A range from its adjusted equity and its earnings, with your own assumptions, recalculated as you go.

Value indication

BELESSENTIAL

BE 1001.518.565
NACE 47.730, Retail sale of pharmaceutical products
latest balance sheet 31-12-2025indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€868 to €868

Midpoint €868 · adjusted equity only

Adjusted equity €868
Indication €868

Your assumptions

Capitalised earnings
%

The return a buyer expects on the money put in. Higher for more risk. The range also computes with 2 points more and less.

Adjust the equity
Blend
50%
Optional: your own multiple

Checked holds no market prices, so it suggests no multiple. If you have one from a transaction or a study, the tool applies it to the filed EBITDA less the net financial debt.

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€868
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€868

Capitalised earnings

net result for the year (9904)
2025
-€253
2024
-€706
2023
-€1,173
Average result
-€711
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful: the average result is zero or negative

What this indication leaves out

  • Market prices and comparable transactions: Checked does not hold them.
  • Anything after the latest accounts, and items off the balance sheet (guarantees, leases, disputes).
  • The real value of buildings, stock and receivables: enter your own revaluation or adjustment.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale.

For a valuation to decide on: a company auditor or a certified accountant.

Source: filed annual accounts (NBB), latest balance sheet at 31 December 2025. Prepared on 28 September 2026 via checked.be. Indication, not a valuation or advice.